JPS56118018A - Drug composition containing myeloperoxidase as main constituent - Google Patents

Drug composition containing myeloperoxidase as main constituent

Info

Publication number
JPS56118018A
JPS56118018A JP2211380A JP2211380A JPS56118018A JP S56118018 A JPS56118018 A JP S56118018A JP 2211380 A JP2211380 A JP 2211380A JP 2211380 A JP2211380 A JP 2211380A JP S56118018 A JPS56118018 A JP S56118018A
Authority
JP
Japan
Prior art keywords
myeloperoxidase
drug composition
halide
leukocyte
originating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2211380A
Other languages
Japanese (ja)
Inventor
Eiichi Hasegawa
Takashi Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP2211380A priority Critical patent/JPS56118018A/en
Priority to SE8005679A priority patent/SE448882B/en
Priority to US06/179,783 priority patent/US4306025A/en
Priority to DE3031990A priority patent/DE3031990C2/en
Priority to FR8018581A priority patent/FR2472609A1/en
Priority to AT0436780A priority patent/AT370997B/en
Priority to IN758/CAL/81A priority patent/IN153488B/en
Priority to US06/297,418 priority patent/US4379141A/en
Publication of JPS56118018A publication Critical patent/JPS56118018A/en
Priority to GB8233109A priority patent/GB2108387B/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: A drug composition, particularly effective atainst resistant tubercle bacillus, and containing myeloperoxidase derived from the leukocyte originating from the human bone marrow and a halide.
CONSTITUTION: A drug composition, effective against bacteria having deficient or reduced catalase synthetic ability, particularly a tubercle bacillus resistant to isonicotinic acid hydrazide, and containing 100W0.05 units myeloperoxidase derived from the leukocyte originating from the human bone marrow and 5W0.05mmol halide, e.g. KI. The myeloperoxidase is an enzyme having a germicidal and antiviral action, capable of producing hypohalite ions in the presence of hydrogen peroxide and halogen ions and believed to exhibit antibacterial action due to the powerful oxidation or halogenating action of the hypohalite. The hydrogen peroxide unusable due to the instability thereof as a medicine can be eliminated by the use of the halide in a specific proportion.
COPYRIGHT: (C)1981,JPO&Japio
JP2211380A 1979-12-28 1980-02-22 Drug composition containing myeloperoxidase as main constituent Pending JPS56118018A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2211380A JPS56118018A (en) 1980-02-22 1980-02-22 Drug composition containing myeloperoxidase as main constituent
SE8005679A SE448882B (en) 1979-12-28 1980-08-12 PROCEDURE FOR THE EXTRACTION OF MYELOPEROXIDAS AND PHARMACEUTICAL COMPOSITION CONTAINING THE ENZYME
US06/179,783 US4306025A (en) 1979-12-28 1980-08-20 Method for recovering myeloperoxidase and pharmaceutical composition containing myeloperoxidase as major constituent
DE3031990A DE3031990C2 (en) 1979-12-28 1980-08-25 Obtaining myeloperoxidase and medicinal products containing this enzyme as the main component
FR8018581A FR2472609A1 (en) 1979-12-28 1980-08-27 PROCESS FOR SEPARATING MYELOPEROXIDASE AND PHARMACEUTICAL COMPOSITION CONTAINING MYELOPEROXIDASE
AT0436780A AT370997B (en) 1979-12-28 1980-08-28 METHOD FOR OBTAINING MYELOPEROXIDASE
IN758/CAL/81A IN153488B (en) 1979-12-28 1981-07-08
US06/297,418 US4379141A (en) 1979-12-28 1981-08-28 Method for recovering myeloperoxidase and pharmaceutical composition containing myeloperoxidase as major constituent
GB8233109A GB2108387B (en) 1979-12-28 1982-11-19 A pharmaceutical composition containing myeloperoxidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2211380A JPS56118018A (en) 1980-02-22 1980-02-22 Drug composition containing myeloperoxidase as main constituent

Publications (1)

Publication Number Publication Date
JPS56118018A true JPS56118018A (en) 1981-09-16

Family

ID=12073825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2211380A Pending JPS56118018A (en) 1979-12-28 1980-02-22 Drug composition containing myeloperoxidase as main constituent

Country Status (1)

Country Link
JP (1) JPS56118018A (en)

Similar Documents

Publication Publication Date Title
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
MY103277A (en) Oderless aromatic dialdehyde disinfecting and sterilizing composition
ES8301904A1 (en) Urea derivatives, preparation and use.
JPS53118516A (en) Inactivation disinfectant of hepatitis-b virus
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
ES470212A1 (en) Process for the disinfection of water
ES8607916A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
TW327627B (en) Water purification material, process of preparation thereof and water purification unit
DE3468212D1 (en) Monohydroxy-benzoyl peroxide and compositions for treating acne
ES2001774A6 (en) Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products.
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
JPS56118018A (en) Drug composition containing myeloperoxidase as main constituent
ES8105993A1 (en) 7-Phenyl-quinolizidine derivatives (I), their preparation, pharmaceutical compositions containing them and (I) for use in treating diseases.
Roberts et al. Chlorine dioxide for wastewater disinfection: a feasibility evaluation
JPS52106836A (en) N-trichloroacetyl-n#-chlorobenzoylhydrazine derivatives and germicide s for agriculture and horticulture containing thereof
ES8403883A1 (en) Substituted benzoyl(thio) ureas, process for their preparation and their use as parasiticides.
ES2017279A6 (en) 2-hydroxy-3-phenoxy-propyl-substituted piperazines and homopiperazines, their manufacture and use.
GR78622B (en)
TW231257B (en)
JPS5518259A (en) Available chlorine activity maintainer in water
JPS53124674A (en) Microbial decomposition of styrene oligomer
JPS5513228A (en) Sterilization composition
ATE235238T1 (en) USE OF 2,3-ALKYLCAEBONYLOXYBENZOIC ACID FOR THE TREATMENT OF RESPIRATORY UNAWARENESS SYDROME IN ADULTS
ES8202811A1 (en) 1,4-Benzodioxines, processes for their preparation and their use in therapy.
DE3264304D1 (en) Use of 2-hydroxy-3,4,4-trimethyl-cyclopent-2-ene-1-one as odorant ingredient